BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19800579)

  • 41. Regulated inactivation of the spindle assembly checkpoint without functional mitotic spindles.
    De Souza CP; Hashmi SB; Yang X; Osmani SA
    EMBO J; 2011 Jun; 30(13):2648-61. PubMed ID: 21642954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative CDC20 translational isoforms tune mitotic arrest duration.
    Tsang MJ; Cheeseman IM
    Nature; 2023 May; 617(7959):154-161. PubMed ID: 37100900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.
    Harley ME; Allan LA; Sanderson HS; Clarke PR
    EMBO J; 2010 Jul; 29(14):2407-20. PubMed ID: 20526282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
    Nakai R; Iida S; Takahashi T; Tsujita T; Okamoto S; Takada C; Akasaka K; Ichikawa S; Ishida H; Kusaka H; Akinaga S; Murakata C; Honda S; Nitta M; Saya H; Yamashita Y
    Cancer Res; 2009 May; 69(9):3901-9. PubMed ID: 19351824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit.
    Wäsch R; Cross FR
    Nature; 2002 Aug; 418(6897):556-62. PubMed ID: 12152084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substrate degradation by the anaphase promoting complex occurs during mitotic slippage.
    Lee J; Kim JA; Margolis RL; Fotedar R
    Cell Cycle; 2010 May; 9(9):1792-801. PubMed ID: 20436289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspases-dependent cleavage of mitotic checkpoint proteins in response to microtubule inhibitor.
    Baek KH; Shin HJ; Jeong SJ; Park JW; McKeon F; Lee CW; Kim CM
    Oncol Res; 2005; 15(3):161-8. PubMed ID: 16050137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homeostatic control of mitotic arrest.
    Varetti G; Guida C; Santaguida S; Chiroli E; Musacchio A
    Mol Cell; 2011 Dec; 44(5):710-20. PubMed ID: 22152475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis.
    Kollareddy M; Sherrard A; Park JH; Szemes M; Gallacher K; Melegh Z; Oltean S; Michaelis M; Cinatl J; Kaidi A; Malik K
    Cancer Lett; 2017 Sep; 403():74-85. PubMed ID: 28602975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
    Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
    Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.
    Russell P; Hennessy BT; Li J; Carey MS; Bast RC; Freeman T; Venkitaraman AR
    Oncogene; 2012 May; 31(19):2450-60. PubMed ID: 22056875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Requirement for proteolysis in spindle assembly checkpoint silencing.
    Visconti R; Palazzo L; Grieco D
    Cell Cycle; 2010 Feb; 9(3):564-9. PubMed ID: 20081372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cdc20: At the Crossroads between Chromosome Segregation and Mitotic Exit.
    Kapanidou M; Curtis NL; Bolanos-Garcia VM
    Trends Biochem Sci; 2017 Mar; 42(3):193-205. PubMed ID: 28202332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depletion of p31comet protein promotes sensitivity to antimitotic drugs.
    Ma HT; Chan YY; Chen X; On KF; Poon RY
    J Biol Chem; 2012 Jun; 287(25):21561-9. PubMed ID: 22544748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
    Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
    J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinesin motor proteins as targets for cancer therapy.
    Huszar D; Theoclitou ME; Skolnik J; Herbst R
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):197-208. PubMed ID: 19156502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of ubiquitylation of components of mitotic checkpoint complex in their dissociation from anaphase-promoting complex/cyclosome.
    Sitry-Shevah D; Kaisari S; Teichner A; Miniowitz-Shemtov S; Hershko A
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1777-1782. PubMed ID: 29432156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.
    Tan CL; Teissier S; Gunaratne J; Quek LS; Bellanger S
    Cell Cycle; 2015; 14(9):1459-70. PubMed ID: 25789401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1.
    Khumukcham SS; Samanthapudi VSK; Penugurti V; Kumari A; Kesavan PS; Velatooru LR; Kotla SR; Mazumder A; Manavathi B
    J Biol Chem; 2019 Jun; 294(26):10236-10252. PubMed ID: 31101654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint.
    Yu B; Liu Y; Luo H; Fu J; Li Y; Shao C
    J Biol Chem; 2021; 296():100276. PubMed ID: 33428943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.